Results 51 to 60 of about 103,888 (259)

Non-thrombocytopenic purpuras

open access: yesActa Dermato-Venereologica, 1978
88 cases of microscopical diapedesis of the red blood cells in the superficial blood vessels of the skin were investigated clinically, histologically and immunohistologically. Polymorphonuclear vasculitis (PMNV) was found in 27 cases, 18 of which also demonstrated immunoglobulins (mostly IgM) in the vessel walls.
K M, Niemi, K, Kangas
openaire   +2 more sources

Opportunities for improving platelet transfusion practice: A large retrospective audit across 22 hospitals

open access: yesBritish Journal of Haematology, EarlyView.
Summary Despite evidence‐based guidelines to inform platelet transfusion practice, unnecessary platelet transfusion persists. We performed a multicentre retrospective analysis of adults admitted to general medicine, subspecialty medicine and critical care from 1 January 2017 to 30 June 2022.
Sarah Ryan   +14 more
wiley   +1 more source

Efficacy and safety of open‐label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study

open access: yesJournal of Thrombosis and Haemostasis, 2019
Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare, life‐threatening autoimmune thrombotic microangiopathy. Caplacizumab, an anti‐von Willebrand Factor Nanobody®, is effective for treating aTTP episodes and is well tolerated.
P. Knoebl   +11 more
semanticscholar   +1 more source

Graves’ disease-induced immune thrombocytopenic purpura in an African female: a case report

open access: yesJournal of Medical Case Reports, 2023
Background Immune thrombocytopenic purpura is a condition associated with an unusual, unexplained, and sometimes very severe reduction in the level of platelets in the blood.
Kwabena Oteng Agyapong   +7 more
doaj   +1 more source

Levels of von Willebrand factor antigen and von Willebrand factor cleaving protease (ADAMTS13) activity predict clinical events in chronic heart failure. [PDF]

open access: yes, 2009
Decreased activity of ADAMTS13, the von Willebrand factor (VWF) cleaving protease, was recently reported in cardiovascular diseases and in hepatic failure.
Borgulya, Gábor   +10 more
core   +1 more source

Medical haematology: Repositioning haematology at the centre of medicine

open access: yesBritish Journal of Haematology, EarlyView.
The complementary domains of Medical Haematology and Haemato‐Oncology share a biological framework. The left panel depicts red cells, platelets, coagulation, thrombosis and innate immunity, while the right panel shows lymphoid and myeloid malignancies.
Cheng Hock Toh, Imelda Bates, Sue Pavord
wiley   +1 more source

Using plasma exchange to successfully manage thyrotoxicosis in a patient with possible antithyroid drug-related thrombotic thrombocytopenic purpura

open access: yesEndocrine Regulations, 2017
Objective. Thrombotic thrombocytopenic purpura (TTP) is a rare disease characterized by microangiopathic hemolytic anemia, thrombocytopenic purpura, neurologic abnormalities, fever, and renal insufficiency.
Tazegul G   +9 more
doaj   +1 more source

Purpura with regular shape in an adolescent: Beware of dermatitis artefacta

open access: yesFrontiers in Pediatrics, 2022
BackgroundPurpura is common in pediatric patients, mostly diagnosed as IgA-related vasculitis (Henoch–Schönlein purpura), idiopathic thrombocytopenic purpura (ITP), and thrombotic thrombocytopenic purpura (TTP). However, in some cases, for example, cases
Yuhao Chen   +4 more
doaj   +1 more source

Intracranial Hemorrhage Due to Secondary Hypertension from Intracranial Large Vessel Occlusion [PDF]

open access: yes, 2020
Simultaneous hemorrhagic and ischemic strokes have been previously reported in the literature. Typically, these occur in patients secondary to dialysis, cerebral amyloid angiopathy, or thrombotic thrombocytopenic purpura.1,2,3 However, this is the unique
Khan, Asif A.   +3 more
core  

Idiopathic thrombocytopenic purpura

open access: yesJapanese Journal of Thrombosis and Hemostasis, 2008
Point(1)診断は血小板減少をきたす他の疾患の除外を基本とする.(2)血小板数と出血症状の程度,背景因子やライフスタイルに基づいて治療適応を決める.(3)治療はまずステロイド療法,次いで摘脾を行う.(4)ITPと診断されればまずH. pyloriを検索し,陽性であれば除菌療法を優先する.
openaire   +3 more sources

Home - About - Disclaimer - Privacy